MANAGED ACCOUNT ADVISORS LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 121 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.5%.

Quarter-by-quarter ownership
MANAGED ACCOUNT ADVISORS LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$4,550,000
+17400.0%
267,965
+12451.1%
0.00%
Q1 2015$26,000
+52.9%
2,135
+3.2%
0.00%
Q4 2014$17,000
-15.0%
2,069
-11.9%
0.00%
Q3 2014$20,000
-31.0%
2,348
-10.8%
0.00%
Q2 2014$29,000
+16.0%
2,633
-6.4%
0.00%
Q1 2014$25,000
+19.0%
2,812
+1.8%
0.00%
Q4 2013$21,0002,7630.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders